跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
OTRIVIN MENTHOL xylometazoline hydrochloride 1 mg/mL nasal spray pump actuated metered dose aerosol
Approved
STANDARD
OTRIVIN MENTHOL xylometazoline hydrochloride 1 mg/mL nasal spray pump actuated metered dose aerosol
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
7bb317e1a7999ef8
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7bb317e1a7999ef8
Product Name
OTRIVIN MENTHOL xylometazoline hydrochloride 1 mg/mL nasal spray pump actuated metered dose aerosol
Artg Id
99690
Artg Name
OTRIVIN MENTHOL xylometazoline hydrochloride 1 mg/mL nasal spray pump actuated metered dose aerosol
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2004-02-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01536-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
7bb317e1a7999ef8
Type
Standard
Back to TGA Approvals
OTRIVIN MENTHOL xylometazoline hydrochloride 1 mg/mL nasal spray pump actuated metered dose aerosol - TGA Drug Approval Details